V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008003 | 250005524 | 1.58 | null | null | 2018-05-01 | 2018-05-01 | Rituximab | 02 | null | 250008458 | IPM |
| 250008004 | 250005525 | 1.69 | 79.5 | Disease modification (D) | 2018-11-29 | 2018-12-01 | CHOP R - 21 days | 02 | N | 250008692 | TRIAL |
| 250008005 | 250005526 | 1.61 | 59 | Palliative (P) | 2014-08-11 | 2014-09-08 | ABVD | N | N | 250008821 | TRIAL |
| 250008006 | 250005526 | null | 0 | Palliative (P) | 2016-02-12 | 2016-02-17 | Trial Unspecified | 02 | N | 250008821 | IPM |
| 250008007 | 250005527 | 1.89 | null | Palliative (P) | 2015-04-28 | 2015-05-06 | CAPECITABINE + OXALIPLATIN | 2 | N | 250008865 | ECX |
| 250008008 | 250005528 | 0 | 89.1 | Disease modification (D) | 2017-10-03 | 2017-10-03 | Trial Unspecified | 02 | N | 250008903 | IPM |
| 250008009 | 250005529 | null | 55 | Not known (9) | 2013-08-23 | 2013-09-02 | Busulfan Oral | 2 | null | 250008946 | CYTARABINE |
| 250008010 | 250005530 | 0 | 74.2 | Disease modification (D) | 2015-09-30 | 2015-09-30 | Pemetrexed | N | N | 250008968 | RUXOLITINIB |
| 250008011 | 250005531 | 1.5 | 73 | Palliative (P) | 2016-09-22 | 2017-02-27 | Oxaliplatin + Modified de Gramont | N | N | 250008992 | CARBOPLATIN + PACLITAXEL |
| 250008012 | 250009893 | null | 67 | Palliative (P) | 2013-05-31 | 2013-05-31 | HSV1716 | N | N | 250009021 | PEMETREXED |
| 250008013 | 250009893 | 1.67 | 78 | null | 2016-03-01 | 2016-03-01 | Trial Unspecified | null | N | 250009021 | RUXOLITINIB |
| 250008014 | 250009893 | 1.5 | 57 | Palliative (P) | 2014-02-24 | 2014-03-23 | Trial Unspecified | null | N | 250009021 | CAPECITABINE + OXALIPLATIN |
| 250008015 | 250005532 | 1.68 | null | Curative (C) | null | 2013-04-20 | BENDAMUSTINE + RITUXIMAB | null | N | 250009200 | IPM |
| 250008016 | 250005533 | null | null | Curative (C) | 2008-04-17 | 2013-03-23 | Azacitidine | 02 | N | 250009282 | PEMETREXED |
| 250008017 | 250005533 | null | null | Palliative (P) | null | 2014-07-29 | Pemetrexed | N | null | 250009282 | PEMETREXED |
| 250008018 | 250005534 | 1.62 | 86.8 | Adjuvant (A) | null | 2017-09-02 | null | N | N | 250009526 | DOXORUBICIN + OLARATUMAB |
| 250008019 | 250005534 | null | 100 | Adjuvant (A) | 2013-10-30 | 2013-10-30 | CYTARABINE | 2 | N | 250009526 | CVP R |
| 250008020 | 250005535 | 0 | null | Palliative (P) | 2015-11-26 | 2015-11-26 | Vinorelbine (oral) | N | N | 250009660 | TEMOZOLOMIDE |
| 250008021 | 250005536 | 1.64 | 54.9 | Disease modification (D) | 2016-01-14 | 2016-03-17 | Docetaxel 75mg/m2 (21 day) | N | N | 250009721 | IPM |
| 250008022 | 250009896 | 1.57 | null | Palliative (P) | 2018-07-01 | 2018-07-01 | Vinorelbine (oral) | N | N | 250009773 | RITUXIMAB |
| 250008023 | 250005537 | 1.81 | 74 | Palliative (P) | 2016-11-26 | 2016-12-06 | CARBOPLATIN | N | N | 250009891 | GEMCARBO |
| 250008024 | 250005537 | 1.72 | 42 | Palliative (P) | 2018-03-31 | 2018-03-31 | Cytarabine Low Dose | null | N | 250009891 | TRIAL |
| 250008025 | 250005537 | 1.73 | 70 | Curative (C) | 2013-09-28 | 2013-10-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250009891 | VINORELBINE |
| 250008026 | 250005537 | null | 77.15 | Adjuvant (A) | 2015-03-22 | 2015-03-22 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 250009891 | PEMETREXED |
| 250008027 | 250005538 | null | null | Palliative (P) | 2014-10-31 | 2014-11-01 | RUXOLITINIB | 2 | N | 250010020 | BEVACIZUMAB |
| 250008028 | 250005538 | 1.67 | null | Curative (C) | 2017-12-03 | 2017-12-04 | CARBOPLATIN + VINORELBINE | 02 | N | 250010020 | TRIAL |
| 250008029 | 250005539 | 1.74 | null | Not known (9) | null | 2017-07-22 | IPM | N | N | 250010067 | UKALL60+ |
| 250008030 | 250009899 | null | null | null | 2016-07-16 | 2016-07-16 | Trial Unspecified | Y | N | 250010101 | GEMCARBO |
| 250008031 | 250011675 | null | 67.4 | Disease modification (D) | 2018-02-26 | 2018-03-19 | Pemetrexed | N | N | 250010178 | TRIAL |
| 250008032 | 250011675 | null | 70 | Disease modification (D) | 2014-05-16 | 2014-05-16 | Pemetrexed | 01 | N | 250010178 | CISPLATIN |
| 250008033 | 250005540 | 1.74 | 69 | Curative (C) | 2015-05-22 | 2015-05-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250010204 | MELPHALAN |
| 250008034 | 250005541 | 1.6 | 61.3 | Palliative (P) | null | 2013-06-01 | Docetaxel 75mg/m2 (21 day) | N | N | 250010247 | PAZOPANIB |
| 250008035 | 250009900 | 1.73 | null | null | null | 2015-01-29 | Azacitidine | null | N | 250010298 | IPM |
| 250008036 | 250011676 | 1.73 | 64 | Not known (9) | 2013-05-16 | 2013-05-16 | Docetaxel 75mg/m2 (21 day) | 2 | N | 250010329 | PCV |
| 250008037 | 250011676 | 1.78 | 71.7 | Curative (C) | 2016-07-20 | 2016-07-22 | RUXOLITINIB | N | N | 250010329 | CARBOPLATIN + PACLITAXEL |
| 250008038 | 250012721 | 1.74 | null | Disease modification (D) | 2018-04-04 | 2018-04-17 | CARBOPLATIN | 99 | N | 250010404 | AZACITIDINE |
| 250008039 | 250012721 | 1.5 | 0 | Curative (C) | 2014-08-17 | 2014-08-17 | Trial Unspecified | N | N | 250010404 | TRIAL |
| 250008040 | 250012721 | 1.72 | 104.1 | null | 2016-01-06 | 2016-01-06 | VEPEMB | null | N | 250010404 | CVP R |
| 250008041 | 250012721 | 1.67 | 91.2 | Palliative (P) | 2017-03-29 | 2017-03-29 | Vinorelbine (oral) | 02 | N | 250010404 | PEMETREXED |
| 250008042 | 250005542 | 0 | null | null | 2018-01-07 | 2018-01-07 | Pemetrexed | null | null | 250010546 | OXALIPLATIN + MDG |
| 250008043 | 250005543 | null | 70.5 | Disease modification (D) | 2016-03-27 | 2016-04-09 | Vinorelbine (oral) | 02 | N | 250010639 | CARBOPLATIN |
| 250008044 | 250009901 | 1.61 | 75.8 | Disease modification (D) | 2014-07-10 | 2014-07-10 | VINORELBINE | 1 | N | 250010667 | CYTARABINE |
| 250008045 | 250009901 | 0 | 79.6 | Palliative (P) | 2016-12-30 | 2016-12-30 | Azacitidine | N | N | 250010667 | AML18 TRIAL |
| 250008046 | 250009901 | null | 73.1 | Curative (C) | 2016-12-18 | 2016-12-18 | RUXOLITINIB | 02 | Y | 250010667 | TRIAL |
| 250008047 | 250009901 | null | null | null | 2017-05-20 | 2017-05-20 | Pemetrexed | Y | null | 250010667 | CYTARABINE |
| 250008048 | 250009901 | 1.75 | null | Palliative (P) | null | 2017-04-23 | Trial Unspecified | Y | null | 250010667 | CAPECITABINE |
| 250008049 | 250005544 | null | null | Palliative (P) | 2017-03-11 | 2017-03-11 | Trial Unspecified | Y | null | 250010744 | VINORELBINE |
| 250008050 | 250005544 | 1.71 | 67.2 | Curative (C) | 2017-06-07 | 2017-06-07 | Cisplatin | 2 | N | 250010744 | VINORELBINE |
| 250008051 | 250005545 | 0 | 91 | Disease modification (D) | 2018-04-02 | 2018-04-02 | Trial Unspecified | N | N | 250010823 | TRIAL |
| 250008052 | 250005546 | null | null | null | 2015-11-04 | 2015-11-04 | Cisplatin | 02 | null | 250010875 | TRIAL |